Greater Glasgow and Clyde Medicines

MHRA Drug Safety Update April 2023

Links to the MHRA Drug Safety Update for April 2023 below.

• Isotretinoin (Roaccutane▼): new safety measures to be introduced in the coming months, including additional oversight on initiation of treatment for patients under 18 years

• Janus kinase (JAK) inhibitors: new measures to reduce risks of major cardiovascular events, malignancy, venous thromboembolism, serious infections and increased mortality

• Nitrofurantoin: reminder of the risks of pulmonary and hepatic adverse drug reactions

• Letters and medicine recalls sent to healthcare professionals in March 2023

You can sign up to receive these alerts directly from the MHRA at: MHRA email alerts

Published 28/04/2023. Medicines Update blogs are correct at the time of publication.

If you would like to subscribe to Medicines Update or provide feedback on the blogs, email medicines.update@ggc.scot.nhs.uk.
Follow Medicines Update on Twitter @NHSGGCMeds